Understanding The Impact Of MRSA On Limb Preservation
|
Point-Counterpoint: Should You Cover MRSA?
|
The Independent Evolution Of Healthcare-Associated And Community-Acquired MRSA
The Independent Evolution Of Healthcare-Associated And Community-Acquired MRSA Feature: The Independent Evolution Of Healthcare-Associated And Community-Acquired MRSA - Prevalence And Risk Factors For MRSA Infections The incidence of Staphylococcus aureus has increased dramatically throughout the United States as a cause of nosocomial infections. SSTIs were more common among CA-MRSA patients (75%) than among HA-MRSA patients (37%). Respiratory tract infections were more common in HA-MRSA (22...
|
MRSA: Where Do We Go From Here?
|
Exploring Current And Emerging Treatments For MRSA
|
Emerging Data, Emerging Agents: Treatment Of Complicated Skin And Soft Tissue Infection
Emerging Data, Emerging Agents: Treatment Of Complicated Skin And Soft Tissue Infection Feature: Emerging Data, Emerging Agents: Treatment Of Complicated Skin And Soft Tissue Infection - The classification of skin and soft tissue infection (SSTI) will ultimately determine therapeutic strategies to be used in the patient. (cSSTIs, including deep soft tissue infections, those requiring surgical intervention [infected ulcers, infected burns, and major abscesses] and those in patients who have ...
|
CME Information
CME Information Feature: CME Information - Target Audience This self-study activity is designed for podiatrists, internists, family practitioners, and surgeons involved in the care and treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Equally alarming is the recent, rapidly rising prevalence of community-acquired MRSA (CA-MRSA), a pathogen that appears to have evolved independently of healthcare-associated MRSA (HA-MRSA). This article will review the ...
|
A Closer Look At Diabetic Foot Infections
|
Current Concepts In Empiric Antibiotic Therapy
|
Can A New Molecular Test Enhance MRSA Detection?
Gatifloxacin? Dr. Kosinski describes levofloxacin as ? The plan by SureScripts is to garner patients?
|
